Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,658,714
-$1,583,116 QoQ
Shares Held
20,031
-60.3% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#146
of 285 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Derivatives in APGE
reported options exposure · as of Mar 31, 2026CallValue
$841,700
CallShares
10,000
PutValue
$8,484,336
PutShares
100,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. APGE ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in APGE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,658,714 | 20,031 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,241,830 | 50,396 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $841,700 | 10,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $8,484,336 | 100,800 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $10,053,406 | 133,193 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $25,519,213 | 642,316 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $26,441,138 | 608,822 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $18,628,630 | 498,625 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $21,597,228 | 476,760 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $21,442,802 | 365,046 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $3,061,547 | 77,803 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,435,126 | 36,646 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $951,524 | 34,056 | Shares | Sole | 2026-03-24 | |
| No filing history on record for this holder in this stock. | ||||||